C
COV
CLEO DIAGNOSTICS
0.57
-0.01-2.56%Closed15:56 02/20 AEDT
OPEN/PREV CLOSE0.585/0.585
TODAY RANGE0.550-0.585
VOL408.69K
MARKET CAP78.01M
52 WEEK RANGE0.310-0.900
AVG VOL (3M)431.85K
% TURNOVER0.30%
TURNOVER231.90K
P/E (TTM)-18.3280
% RANGE5.98%
EPS(TTM)-0.0311
P/E(FORWARD)--
P/B12.56
BVPS0.045
DIVIDEND--
P/S61.96
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP47.49M
SHARES OUTSTANDING136.86M
NEXT EARNINGS--
FREE FLOAT83.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/28 21:27
Quarterly activities and cashflow report
ASX·01/05 04:27
Ceasing to be a substantial holder
ASX·12/29/2025 00:25
Chairman's End of Year Letter to Shareholders
ASX·12/29/2025 00:17
Cleansing Notice
ASX·12/29/2025 00:13
Notification regarding unquoted securities - COV
ASX·12/29/2025 00:05
Application for quotation of securities - COV
ASX·12/17/2025 22:55
Proposed issue of securities - COV
ASX·12/17/2025 22:55
CLEO Raises $5m to Support U.S. Market Launch
ASX·12/16/2025 21:51
Trading Halt
ASX·11/28/2025 05:33
Notice under Listing Rule 3.10A
ASX·11/25/2025 21:27
Cleo Strengthens Cash Position with $1.7m R&D Tax Refund
ASX·11/24/2025 03:40
Results of Annual General Meeting
ASX·11/18/2025 17:05
CLEO Appoints First Key Opinion Leader to Support US Market
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others